AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 182 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 6.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $313,000 | +8.3% | 33,325 | -11.7% | 0.00% | 0.0% |
Q2 2020 | $289,000 | +24.0% | 37,725 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $233,000 | -50.2% | 37,725 | -1.8% | 0.00% | 0.0% |
Q4 2019 | $468,000 | +4.9% | 38,425 | -0.5% | 0.00% | 0.0% |
Q3 2019 | $446,000 | +15.5% | 38,625 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $386,000 | -22.3% | 38,625 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $497,000 | -15.3% | 38,625 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $587,000 | -24.1% | 38,625 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $773,000 | +2.7% | 38,625 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $753,000 | -3.2% | 38,625 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $778,000 | +70.2% | 38,625 | +11.9% | 0.00% | +100.0% |
Q4 2017 | $457,000 | +65.0% | 34,525 | +129.8% | 0.00% | 0.0% |
Q3 2017 | $277,000 | +0.7% | 15,025 | +0.7% | 0.00% | 0.0% |
Q2 2017 | $275,000 | -51.8% | 14,925 | -41.1% | 0.00% | 0.0% |
Q1 2017 | $571,000 | -35.2% | 25,325 | 0.0% | 0.00% | -50.0% |
Q4 2016 | $881,000 | +49.1% | 25,325 | +5.0% | 0.00% | 0.0% |
Q3 2016 | $591,000 | +21.6% | 24,125 | +18.7% | 0.00% | +100.0% |
Q2 2016 | $486,000 | +45.9% | 20,325 | +42.9% | 0.00% | 0.0% |
Q1 2016 | $333,000 | – | 14,225 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |